Curiva is headquartered in Goshen, Indiana and has been in operation for 2 years.
Curiva is committed to reducing the incidence of cervical cancer by delivering faster, more accurate results through a non-invasive diagnostic patch. Our patient-centric products deliver accurate, same-day results while reducing diagnostic costs for healthcare providers.
A microneedles mediated diagnostic patch, diaPatch™, that detects the early onset of cervical cancer, replacing invasive procedures such as the Pap smear and colposcopy. The digitized medical device is able to detect novel targets within 30 min. - equivalent to a clinical visit. Overall, diaPatch™ will provide benefits to healthcare professionals for better management of guidelines and improved patient outcomes.